SAGE Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 56 U.S.-traded ETFs. SAGE has around 6.6M shares in the U.S. ETF market. The largest ETF holder of SAGE is the SPDR S&P Biotech ETF (XBI), with approximately 1.78M shares. Investors may also find of interest that the ETF with the largest allocation to SAGE stock is PSYK ETF (PSYK), with a portfolio weight of 8.03%. On average, U.S. ETFs allocate 0.41% of SAGE to their portfolios.
Additionally, SAGE is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with SAGE as a holding is the Avantis U.S. Small Cap Equity ETF (AVSC), with a return of --.